Sectors

Drugs manufacturer Indivior has had £1bn ($1.3 billion) wiped off their value as a result of it losing a US patent dispute over its heroin treatment substitute. Reports indicate that the patent dispute between Reckitt Benckiser and Dr Reddy’s that was first ruled upon in 2014 has taken a vicious turn, as an appeal against the 2014 decision that…